ArticleNeuro-oncology advances

Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time.

Erica A Power et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.